| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;113:1865-1870.)
© 2006 American Heart Association, Inc.
Imaging |
From the National Heart, Lung and Blood Institute, National Institutes of Heath, US Department of Health and Human Services, Bethesda, Md (A.H.A., G.S.T., A.N., L.-Y.H., F.M.G., R.F.H., A.E.A.); and Mount Sinai School of Medicine, New York, NY (A.N.).
Correspondence to Andrew Arai, MD, National Heart, Lung and Blood Institute, National Institutes of Health, Bldg 10, Room B1D416, MSC 1061, Bethesda, MD 20892-1061. E-mail AraiA{at}nhlbi.nih.gov
Received July 14, 2005; revision received January 27, 2006; accepted February 1, 2006.
| Abstract |
|---|
|
|
|---|
Methods and Results Seventeen dogs underwent a 90-minute coronary artery occlusion, followed by reperfusion. The area at risk, as measured with microspheres (9 animals), was comparable to the size of the hyperintense zone on T2-weighted images 2 days later (43.4±3.3% versus 43.0±3.4% of the left ventricle; P=NS), and the 2 measures correlated (R=0.84). The infarcted zone was significantly smaller (23.1±3.7; both P<0.001). To test whether the hyperintense myocardium would exhibit partial functional recovery over time, 8 animals were imaged on day 2 and 2 months later. Systolic strain was mapped with displacement encoding with stimulated echoes. Edema, as detected by a hyperintense zone on T2-weighted images, resolved, and regional radial systolic strain partially improved from 4.9±0.7 to 13.1±1.5 (P=0.001) over 2 months.
Conclusions These findings are consistent with the premise that the T2 abnormality depicts the area at risk, a zone of reversibly and irreversibly injured myocardium associated with reperfused subendocardial infarctions. The persistence of postischemic edema allows T2-weighted CMR to delineate the area at risk 2 days after reperfused myocardial infarction.
Key Words: contractility edema magnetic resonance imaging myocardial infarction myocardial strain
| Introduction |
|---|
|
|
|---|
Measuring the area at risk is difficult in patients with acute myocardial infarction (MI). Ideally, imaging the area at risk should be simple, yield high-quality images that are easily registered with infarct images, and avoid interfering with acute patient management. Sestamibi single-photon emission computed tomography (SPECT) allows imaging after the patient is stabilized but requires radiotracer administration during ischemia. The need for radioactive tracers in an emergency department setting and the low spatial resolution of the method have limited this approach. Similar approaches may be feasible with manganese-enhanced cardiac magnetic resonance (CMR).9 Prolonged abnormalities in metabolism may highlight the area at risk and allow administration of newer SPECT agents after intervention.10
Editorial p 1821
Clinical Perspective p 1870
T2-weighted (T2W) CMR may provide an alternative approach. Many studies have correlated T2W CMR against infarct size, but the results generally show that T2 overestimates infarct size.11 Instead, T2W imaging may highlight myocardial edema and therefore could delineate the area at risk.
The aim of the present study was to determine whether edema imaging by T2W CMR could be used as an imaging tool for retrospectively delineating the hypoperfused area at risk in reperfused MI. It was hypothesized that the area at risk by fluorescent microspheres during a transient occlusion would be of similar size to the T2 abnormality observed 2 days later with CMR, and the infarcted zone would be a subset of the area at risk. Also, it was hypothesized that the T2W hyperintense region would resolve and show partial functional recovery after 2 months, which would be consistent with the premise that it encompassed a combination of some stunned myocardium and some infarcted myocardium.
| Methods |
|---|
|
|
|---|
Relation Between Measures of Area at Risk
To compare the size of the T2W abnormality with the area at risk and the infarcted zone, 9 animals were studied. To obtain an adequate range of area at risk measurements for correlation statistics, 3 short-axis slices per animal were used (basal, mid, apical). Approximately 5x106 fluorescent microspheres (Interactive Medical Technologies, Irvine, Calif) were injected into the left atrial catheter at the time of the occlusion to determine the area at risk. Two days later, this group of 9 animals underwent 1.5-T CMR edema imaging (T2W imaging). After euthanasia, infarct size was defined by triphenyltetrazolium chloride (TTC) staining.
Resolution of T2 Abnormality and Functional Recovery Within the Area at Risk
To demonstrate that the T2W abnormality included both stunned and infarcted myocardium, the functional recovery of systolic strain was imaged in another group of 8 animals 2 days after occlusion and was repeated 2 months later. For these 8 animals, infarct size was quantified 2 days after occlusion by gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) delayed-enhancement CMR images rather than relying on 2-month chronically remodeled TTC histopathological samples. One midventricular slice per animal was used for the functional recovery analysis.
Imaging Parameters
First, edema imaging was performed with T2W double-inversion blood-suppressed fast-spin-echo magnetic resonance imaging (MRI)13 with parameters as follows: 1.1x1.1x4-mm3 voxel, ±62-kHz bandwidth, 62.2-ms echo time (TE), 4- to 6-heartbeat repetition time (TR), 12-echo train length, and 4 averages. Second, left ventricular (LV) systolic strain was imaged using displacement encoding with stimulated echoes (DENSE)14,15 acquired at a spatial resolution of 1.0x1.0x7.0 mm3, ±32-kHz bandwidth, 6.5-ms TE, 2-heartbeat TR, 12-echo train length, 1.2-mm/
encoding strength, and 4 averages. The DENSE gradient encoding strength was adjusted so that the antiecho was shifted out of the sampled k-space window. Last, delayed-enhancement viability imaging was performed
20 minutes after injection of intravenous Gd-DTPA with the following parameters: 1.1x1.1x8-mm3 voxel, ±32-kHz bandwidth, 3.6-ms TE, 2- to 3-heartbeat TR, and phase-sensitive image reconstruction.16 The inversion time was adjusted to null the normal myocardium.17 A 20-heartbeat maximum per breathhold was allowed, and all acquisitions were done during suspended respiration.
Histopathology and Image Processing
The hearts were excised and immersed in isotonic agar solution. Once the agar solidified, hearts were sliced in 4-mm-thick sections with a commercial meat slicer. TTC staining was performed to demarcate the infarcted region.18 Briefly, the myocardial slices were immersed in a 1% TTC solution in saline at 37°C for
4 minutes and then rinsed with physiological saline. Subsequently, 2 consecutive 4-mm slices were matched to the 8-mm CMR slice of interest by registering the total number of short-axis ex vivo slices obtained to the total number of short-axis CMR images obtained from the apex to the mitral valve plane. These two 4-mm slices were each sectioned into 16 transmural circumferential sectors for fluorescent microsphere counting. Every 2 tissue samples corresponding to the same transmural circumferential sector of the two 4-mm slices were paired together for this purpose. The anterior right ventricular insertion point was used to align these samples to the CMR images. For comparison with the microsphere sectors, T2W images were similarly sectioned by software into circumferential sectors and analyzed in that manner. Infarct size was determined automatically with in-house software by counting the number of pixels within the TTC-negative stained area. To allow for better cross-registration along the circumferential direction, both microsphere and CMR 16 sector data were linearly interpolated by a factor of 2 (32 circumferential sectors total).
The CMR infarcted region was quantified by a computer algorithm after manual image tracing of epicardial and endocardial borders.19,20 T2W and contrast-enhanced areas were measured on the basis of 50% of the peak myocardial signal intensities (half-height threshold). Color maps of intramural myocardial strain were reconstructed by custom software.14,21 Hypokinetic myocardium was defined as areas with <10% radial thickening. Abnormal blood flow was defined as <50% blood flow relative to a remote zone, which encompassed the sectors of highest blood flow within the slice.
Statistical Analysis
All areas are described as percent of the LV area. Results are mean±SEM. The sizes of the T2 abnormality, area at risk, and infarct zone were compared by use of paired t tests with Bonferroni correction for multiple comparisons. Linear correlation and Bland-Altman analysis were used to compare the size of the T2 abnormality with the area at risk. Because 2 to 3 myocardial slices were analyzed for each of the 9 animals used for area at risk comparisons (a total of 24 slices), a generalized linear model for repeated measures was performed with SPSS (version 11.0.1, SPSS Inc, Chicago, Ill). Repeated-measures ANOVA was used to test for differences in strain by zone over time. Value of P>0.05 were considered not significant. Signal-to-noise ratio was defined as the mean signal intensity within a region of interest divided by the mean value of the noise. Contrast-to-noise ratio within 2 regions of interest was defined as the difference of their signal-to-noise ratios.
The authors had full access to the data and take full responsibility for its integrity. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
|
Good correlation (R=0.84) was observed between area at risk measurements by microspheres and the size of the corresponding T2W abnormalities (Figure 2, top). The Bland-Altman plot (Figure 2, bottom) showed no bias. Intrasubject correlations were not significant in the generalized linear model for repeated measures.
|
Resolution of T2 Abnormality and Functional Recovery Within the Area at Risk
Figure 3 (top row) shows delayed-enhancement, end-diastolic cine, T2W, and DENSE radial thickening strain images acquired from 1 of the 8 animals followed up over 2 months. The MI seen in the acute delayed-enhancement image is a fraction of both the T2W abnormality and the hypokinetic zone on the DENSE systolic strain map. Note that the acute MI is subendocardial, whereas both the T2 abnormality and the hypokinetic zone appear almost transmural. The relationships between infarct size, size of the T2W abnormality, and size of the hypokinetic zone were typical of the overall group averages (infarct, 19.5±2.3; T2W, 46.4±4.8; DENSE, 55.6±7.2; all P<0.001, except T2W versus DENSE [P=NS]).
|
After 2 months (Figure 3, bottom row), the acute T2 abnormality resolved and function improved in this small subendocardial infarction. On average, the T2W abnormality on day 2 was brighter than the remote zone (signal-to-noise ratio, 10.9±1.1 versus 8.0±1.1; P=0.001; n=8). Two months later, the 2 regions were isointense (9.3±1.5 versus 9.1±1.4; P=NS; n=8). The contrast-to-noise ratio on day 2 was significantly different than 2 months later (2.9±0.8 versus 0.3±0.4; P=0.01).
Figure 4 summarizes regional recovery of function over a 2-month period within the hyperintense area in acute T2W images for all 8 animals in the 2-month follow-up group. Two days after acute MI, the DENSE systolic radial strain was severely reduced in the myocardium within the abnormal T2 zone compared with remote myocardium (4.9±0.7% versus 29.5±2.1% strain; P<0.001). Significant recovery of regional contractile function was observed in the abnormal T2 zone after 2 months (13.1±1.5% strain; P=0.001 versus day 2). However, the recovery of function was only partial, and this zone still exhibited significantly lower radial strain than remote myocardium (24.2±2.0% strain; P=0.001). Initial hyperkinesis in the remote zone decreased at the month 2 follow-up (P=0.017).
|
Similar results were seen for circumferential strain on day 2 (T2 zone, 5.9±0.7% strain; remote, 22.0±1.4% strain; P<0.001). Circumferential strain in the abnormal T2 zone recovered to 12.6±1.2% strain (P=0.001 versus day 2) but only partially relative to the remote zone (17.6±2.2% strain; P=0.006). Initial circumferential strain hyperkinesis in the remote zone decreased at the month 2 follow-up (P=0.015).
| Discussion |
|---|
|
|
|---|
Although many factors can theoretically affect myocardial T2, total tissue water content and an exchange diffusion mechanism22 dominate image contrast. T2 measures low-frequency components of molecular motion and the related nuclear interactions, which result in spin dephasing and signal loss. In muscle, T2 species of 20 µs have been attributed to rigid membranes and protein structures. T2 species of bound water and the corresponding macromolecules also exhibit short T2 values on the order of 5 ms. Both these short T2 species are not observable with the long echo times (
60 ms) used here. An observable T2 species (140 ms), which has been attributed to highly mobile hydrogen on fatty acids, accounts for only 7% of the MR signal. On the other hand, mobile water in muscle (T2,
40 ms) contributes 75% to the signal22 and therefore dominates contrast in T2W imaging of muscle. As a result, increased mobile water content associated with edema appears hyperintense in T2W CMR images.
Pathological studies performed by Reimer and Jennings23 suggest that edema and inflammation are present transmurally, not limited just to the infarcted myocardium, with a reported 25% increase in total water content. In ex vivo imaging studies, Garcia-Dorado et al24 showed that T2 abnormalities closely correlated with increased total water content and accurately depicted the area at risk in a porcine ischemia reperfusion model. In infarcted perfused hearts, Boxt et al25 found similar correlations between T2 and myocardial total water content.
Ischemic myocardium shifts from aerobic metabolism to anaerobic glycolysis and ceases to contract. Lactate starts increasing 4-fold in the damaged tissue within minutes after the onset of ischemia.26 As the high-energy phosphates are depleted and the adenine nucleotide pool is catabolized, a range of osmotically active particles accumulates. Therefore, an osmolar load builds within the cell, resulting in water influx. T2W MRI potentially reflects this increase in water content with increased signal intensity. This effect lasts for days after the initial ischemic episode.27
In acute MI, edema in the peri-infarct zone results from balanced water content increases in both the extracellular and intracellular compartment volumes of viable myocardium.28 Within acutely infarcted myocardium, there is a conversion of intracellular space into extracellular space as a result of cell lysis.28 Because of the increased total water content and increased water mobility, both the peri-infarct and the infarcted zones appear hyperintense on T2W images.
Delayed-enhancement CMR17,29 for acute viability assessment relies on Gd-DTPA, which does not traverse cell membranes but remains within the extracellular space.30,31 Importantly, delayed-enhancement imaging shows the relative sizes of the extracellular and intracellular volumes, ie, the volume of distribution.32,33 For edematous viable myocardium, this ratio has not been substantially altered28; therefore, the peri-infarct zone does not exhibit significant contrast enhancement. On the other hand, the acute infarct demonstrates delayed contrast enhancement as a result of the disproportionately increased apparent extracellular space.34
DENSE14 allowed mapping intramural systolic strain at a resolution comparable to that of the infarct and the T2W images. The fundamental resolution of the DENSE experiment is equivalent to
1000 ultrasonic crystals implanted in a single short-axis slice of myocardium, all spaced a uniform 1 mm apart. The strain maps derived from the DENSE CMR show that the functional deficit in the acute setting is more comparable in size to the T2 enhanced zone than the infarcted region. Functional recovery after 2 months, measured by DENSE, confirms the presence of reversible injury within the partially infarcted area at risk.
Study Limitations
The present study does not address the issue of potentially increased water content in stunned myocardium in the absence of infarction and does not test how well these methods will work in nonreperfused infarctions. For comparing the area at risk by microspheres to the T2 abnormality, the average myocardial mass interrogated with microspheres was 650 mg, whereas the T2 voxels corresponded to 4.8 mg. Thus, the reference standard is much lower resolution than the T2W images being validated. The differences in resolution may contribute to the scatter between these measures. Using smaller tissue samples for microsphere analysis might not provide accurate flow measures.35 Also, the remote zone was defined by the highest myocardial flow within each slice. Selecting a single remote zone within the basal slice to analyze all 3 slices yielded similar results (not presented here), but different methods of threshold selection could potentially influence the magnitude of the results. Finally, for the correlation and agreement analyses, 1 apical and 2 basal slices of 27 could not be analyzed because of arrhythmias, which resulted in poor image quality.
Conclusions
Microsphere area at risk measurements correlate with the corresponding T2 abnormalities. The area at risk and the T2 abnormality were similar in size, and both were significantly larger than the infarcted zone. This suggested that the T2 hyperintense region encompassed both viable and infarcted myocardium associated with the area at risk. In support of this hypothesis, partial functional recovery was observed with high-resolution DENSE during the time when the T2 abnormality resolved. Therefore, edema imaging with T2W CMR delineates the area at risk 2 days after reperfused MI.
| Acknowledgments |
|---|
Disclosures
None.
| References |
|---|
|
|
|---|
2. Horstick G, Heimann A, Gotze O, Hafner G, Berg O, Boehmer P, Becker P, Darius H, Rupprecht HJ, Loos M, Bhakdi S, Meyer J, Kempski O. Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion. Circulation. 1997; 95: 701708.
3. Okamura T, Miura T, Iwamoto H, Shirakawa K, Kawamura S, Ikeda Y, Iwatate M, Matsuzaki M. Ischemic preconditioning attenuates apoptosis through protein kinase C in rat hearts. Am J Physiol. 1999; 277 (pt 2): H1997H12001.[Medline] [Order article via Infotrieve]
4. Neuhof C, Fabiunke V, Deibele K, Speth M, Moller A, Lubisch W, Fritz H, Tillmanns H, Neuhof H. Reduction of myocardial infarction by calpain inhibitors A-705239 and A-705253 in isolated perfused rabbit hearts. Biol Chem. 2004; 385: 10771082.[CrossRef][Medline] [Order article via Infotrieve]
5. Merrill GF, Rork TH, Spiler NM, Golfetti R. Acetaminophen and myocardial infarction in dogs. Am J Physiol Heart Circ Physiol. 2004; 287: H1913H1920.
6. Santoro GM, Bisi G, Sciagra R, Leoncini M, Fazzini PF, Meldolesi U. Single photon emission computed tomography with technetium-99m hexakis 2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. J Am Coll Cardiol. 1990; 15: 301314.[Abstract]
7. Gibbons RJ. Technetium 99m sestamibi in the assessment of acute myocardial infarction. Semin Nucl Med. 1991; 21: 213222.[CrossRef][Medline] [Order article via Infotrieve]
8. Wackers FJ, Gibbons RJ, Verani MS, Kayden DS, Pellikka PA, Behrenbeck T, Mahmarian JJ, Zaret BL. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol. 1989; 14: 861873.[Abstract]
9. Natanzon A, Aletras AH, Hsu L-Y, Arai AE. Determining canine myocardial area at risk with manganese-enhanced MR imaging. Radiology. In press.
10. Tamaki N, Morita K, Tsukamoto E, Kawai Y. Future aspects of BMIPP. Int J Card Imaging. 1999; 15: 7989.[CrossRef][Medline] [Order article via Infotrieve]
11. Miller S, Helber U, Kramer U, Hahn U, Carr J, Stauder NI, Hoffmeister HM, Claussen CD. Subacute myocardial infarction: assessment by STIR T2-weighted MR imaging in comparison to regional function. Magma. 2001; 13: 814.[CrossRef][Medline] [Order article via Infotrieve]
12. Weiss CR, Aletras AH, London JF, Taylor JL, Epstein FH, Wassmuth R, Balaban RS, Arai AE. Stunned, infarcted, and normal myocardium in dogs: simultaneous differentiation by using gadolinium-enhanced cine MR imaging with magnetization transfer contrast. Radiology. 2003; 226: 723730.
13. Simonetti OP, Finn JP, White RD, Laub G, Henry DA. "Black blood" T2-weighted inversion-recovery MR imaging of the heart. Radiology. 1996; 199: 4957.
14. Aletras AH, Ding S, Balaban RS, Wen H. DENSE: displacement encoding with stimulated echoes in cardiac functional MRI. J Magn Reson. 1999; 137: 247252.[CrossRef][Medline] [Order article via Infotrieve]
15. Aletras AH, Wen H. Mixed echo train acquisition displacement encoding with stimulated echoes: an optimized DENSE method for in vivo functional imaging of the human heart. Magn Reson Med. 2001; 46: 523534.[CrossRef][Medline] [Order article via Infotrieve]
16. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002; 47: 372383.[CrossRef][Medline] [Order article via Infotrieve]
17. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100: 19922002.
18. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J. 1981; 101: 593600.[CrossRef][Medline] [Order article via Infotrieve]
19. Hsu L-Y, Natanzon A, Kellman P, Hirsch GA, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI, part I: animal validation of an automated feature analysis and combined thresholding (FACT) infarct sizing algorithm. J Magn Reson Imaging. 2006; 23: 298308.[CrossRef][Medline] [Order article via Infotrieve]
20. Hsu L-Y, Ingkanisorn WP, Kellman P, Aletras AH, Arai AE. Quantitative myocardial infarction on delayed enhancement MRI, part II: clinical application of an automated feature analysis and combined thresholding (FACT) infarct sizing algorithm. J Magn Reson Imaging. 2006; 23: 309314.[CrossRef][Medline] [Order article via Infotrieve]
21. Aletras AH, Balaban RS, Wen H. High-resolution strain analysis of the human heart with fast-DENSE. J Magn Reson. 1999; 140: 4157.[CrossRef][Medline] [Order article via Infotrieve]
22. Bottomley PA, Foster TH, Argersinger RE, Pfeifer LM. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1100 MHz: dependence on tissue type, NMR frequency, temperature, species, excision, and age. Med Phys. 1984; 11: 425448.[CrossRef][Medline] [Order article via Infotrieve]
23. Reimer KA, Jennings RB. The changing anatomic reference base of evolving myocardial infarction: underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation. Circulation. 1979; 60: 866876.
24. Garcia-Dorado D, Oliveras J, Gili J, Sanz E, Perez-Villa F, Barrabes J, Carreras MJ, Solares J, Soler-Soler J. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res. 1993; 27: 14621469.[Medline] [Order article via Infotrieve]
25. Boxt LM, Hsu D, Katz J, Detweiler P, McLaughlin S, Kolb TJ, Spotnitz HM. Estimation of myocardial water content using transverse relaxation time from dual spin-echo magnetic resonance imaging. Magn Reson Imaging. 1993; 11: 375383.[CrossRef][Medline] [Order article via Infotrieve]
26. Jennings RB, Murry CE, Steenbergen C Jr, Reimer KA. Development of cell injury in sustained acute ischemia. Circulation. 1990; 82 (suppl): II-2II-12.[Medline] [Order article via Infotrieve]
27. Pflugfelder PW, Wisenberg G, Prato FS, Turner KL, Carroll SE. Serial imaging of canine myocardial infarction by in vivo nuclear magnetic resonance. J Am Coll Cardiol. 1986; 7: 843849.[Abstract]
28. Li G, Xiang B, Dai G, Shaw A, Liu H, Yang B, Jackson M, Deslauriers R, Tian G. Tissue edema does not change gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)-enhanced T1 relaxation times of viable myocardium. J Magn Reson Imaging. 2005; 21: 744751.[CrossRef][Medline] [Order article via Infotrieve]
29. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol. 2000; 36: 19851991.
30. Goldstein EJ, Burnett KR, Hansell JR, Casaia J, Dizon J, Farrar B, Gelblum D, Wolf GL. Gadolinium DTPA (an NMR proton imaging contrast agent): chemical structure, paramagnetic properties and pharmacokinetics. Physiol Chem Phys Med NMR. 1984; 16: 97104.[Medline] [Order article via Infotrieve]
31. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol. 1984; 142: 619624.
32. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med. 1996; 36: 684693.[Medline] [Order article via Infotrieve]
33. Pereira RS, Prato FS, Sykes J, Wisenberg G. Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA: further studies at early and late periods of reperfusion. Magn Reson Med. 1999; 42: 6068.[CrossRef][Medline] [Order article via Infotrieve]
34. Klein C, Nekolla SG, Balbach T, Schnackenburg B, Nagel E, Fleck E, Schwaiger M. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging. 2004; 20: 588593.[CrossRef][Medline] [Order article via Infotrieve]
35. Decking UK, Pai VM, Bennett E, Taylor JL, Fingas CD, Zanger K, Wen H, Balaban RS. High-resolution imaging reveals a limit in spatial resolution of blood flow measurements by microspheres. Am J Physiol Heart Circ Physiol. 2004; 287: H1132H1140.
Related Articles:
This article has been cited by other articles:
CLINICAL PERSPECTIVE
The study of reperfusion therapies for acute myocardial infarction (MI) has been aided by an understanding of the importance of the initial area at risk, the degree of salvage, and the final infarct size. Infarct size can be determined by radionuclide single-photon emission computed tomography (SPECT) imaging, cardiac magnetic resonance (CMR), and computed tomography (CT). Measurement of area at risk by SPECT 99mTC sestamibi imaging was validated, but these images can be challenging to obtain in the setting of a clinical trial. This study uses microspheres to validate that high-quality T2-weighted (T2W) CMR imaging can determine the area at risk up to 2 days after an experimental acute infarction, taking advantage of the concept that the bright abnormality on T2W images likely represents myocardial edema. These T2W images of area at risk can be performed as part of a more comprehensive CMR examination of MI that also includes infarct size (by delayed-enhancement gadolinium imaging), regional and global function, and myocardial perfusion. Moreover, we also demonstrate that within the partially infarcted area at risk, strain maps of regional contractile function using a method known as displacement encoding with stimulated echoes (DENSE) demonstrate that noninfarcted tissue within the area at risk involve a reversible contractile abnormality in these reperfused infarcts. These CMR methods have excellent potential for translation to clinical practice. Thus, it should be possible to assess the area at risk, infarct size, and myocardial salvage in 1 examination scheduled after patient stabilization (approximately 2 days after MI). This should be a powerful way of assessing the efficacy of infarct reduction and reperfusion therapies.
Circulation 2006 113: 1817.
Circulation 2006 113: 1821-1823.
![]() |
L. Gomez, B. Li, N. Mewton, I. Sanchez, C. Piot, M. Elbaz, and M. Ovize Inhibition of mitochondrial permeability transition pore opening: translation to patients Cardiovasc Res, July 15, 2009; 83(2): 226 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsujioka, T. Imanishi, H. Ikejima, A. Kuroi, S. Takarada, T. Tanimoto, H. Kitabata, K. Okochi, Y. Arita, K. Ishibashi, et al. Impact of Heterogeneity of Human Peripheral Blood Monocyte Subsets on Myocardial Salvage in Patients With Primary Acute Myocardial Infarction. J. Am. Coll. Cardiol., July 7, 2009; 54(2): 130 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. O'Regan, R. Ahmed, C. Neuwirth, Y. Tan, G. Durighel, J. V. Hajnal, I. Nadra, S. J. Corbett, and S. A. Cook Cardiac MRI of myocardial salvage at the peri-infarct border zones after primary coronary intervention Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H340 - H346. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carlsson, J. F.A. Ubachs, E. Hedstrom, E. Heiberg, S. Jovinge, and H. Arheden Myocardium at risk after acute infarction in humans on cardiac magnetic resonance quantitative assessment during follow-up and validation with single-photon emission computed tomography. J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 569 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Friedrich A closer look on the battlefield the salvaged area at risk as an outcome marker for myocardial reperfusion. J. Am. Coll. Cardiol. Img., May 1, 2009; 2(5): 577 - 579. [Full Text] [PDF] |
||||
![]() |
M. G. Friedrich, U. Sechtem, J. Schulz-Menger, G. Holmvang, P. Alakija, L. T. Cooper, J. A. White, H. Abdel-Aty, M. Gutberlet, S. Prasad, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1475 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abdel-Aty, M. Cocker, C. Meek, J. V. Tyberg, and M. G. Friedrich Edema as a very early marker for acute myocardial ischemia a cardiovascular magnetic resonance study. J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1194 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Klocke Emerging applications of t(2)-weighted cardiac magnetic resonance imaging in acute ischemic syndromes. J. Am. Coll. Cardiol., April 7, 2009; 53(14): 1202 - 1203. [Full Text] [PDF] |
||||
![]() |
T. Lockie, E. Nagel, S. Redwood, and S. Plein Use of Cardiovascular Magnetic Resonance Imaging in Acute Coronary Syndromes Circulation, March 31, 2009; 119(12): 1671 - 1681. [Full Text] [PDF] |
||||
![]() |
D. P. O'Regan, R. Ahmed, N. Karunanithy, C. Neuwirth, Y. Tan, G. Durighel, J. V. Hajnal, I. Nadra, S. J. Corbett, and S. A. Cook Reperfusion Hemorrhage Following Acute Myocardial Infarction: Assessment with T2* Mapping and Effect on Measuring the Area at Risk Radiology, March 1, 2009; 250(3): 916 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Wu Fighting the "Fire" of Myocardial Reperfusion Injury: How to Define Success? J. Am. Coll. Cardiol., February 24, 2009; 53(8): 730 - 731. [Full Text] [PDF] |
||||
![]() |
H. Thiele, J. Friedenberger, I. Eitel, G. Furnau, E. Grebe, S. Erbs, A. Linke, S. Mobius-Winkler, G. Schuler, K. Schindler, et al. Response to Letter Regarding Article, "Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention" Circulation, January 27, 2009; 119(3): e20 - e20. [Full Text] [PDF] |
||||
![]() |
M.-T. Wu, M.-Y. M. Su, Y.-L. Huang, K.-R. Chiou, P. Yang, H.-B. Pan, T. G. Reese, V. J. Wedeen, and W.-Y. I. Tseng Sequential Changes of Myocardial Microstructure in Patients Postmyocardial Infarction by Diffusion-Tensor Cardiac MR: Correlation With Left Ventricular Structure and Function Circ Cardiovasc Imaging, January 1, 2009; 2(1): 32 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Engblom, E. Hedstrom, E. Heiberg, G. S. Wagner, O. Pahlm, and H. Arheden Rapid Initial Reduction of Hyperenhanced Myocardium After Reperfused First Myocardial Infarction Suggests Recovery of the Peri-Infarction Zone: One-Year Follow-Up by MRI Circ Cardiovasc Imaging, January 1, 2009; 2(1): 47 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Arai Using Magnetic Resonance Imaging to Characterize Recent Myocardial Injury: Utility in Acute Coronary Syndrome and Other Clinical Scenarios Circulation, August 19, 2008; 118(8): 795 - 796. [Full Text] [PDF] |
||||
![]() |
H. Thiele, K. Schindler, J. Friedenberger, I. Eitel, G. Furnau, E. Grebe, S. Erbs, A. Linke, S. Mobius-Winkler, D. Kivelitz, et al. Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial Circulation, July 1, 2008; 118(1): 49 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Davidson Can the Off-Pump Coronary Artery Bypass Debate Shed Light on Postoperative Right Heart Dysfunction? Circulation, April 29, 2008; 117(17): 2181 - 2183. [Full Text] [PDF] |
||||
![]() |
M. G. Friedrich, H. Abdel-Aty, A. Taylor, J. Schulz-Menger, D. Messroghli, and R. Dietz The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1581 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Thibault, C. Piot, P. Staat, L. Bontemps, C. Sportouch, G. Rioufol, T. T. Cung, E. Bonnefoy, D. Angoulvant, J.-F. Aupetit, et al. Long-Term Benefit of Postconditioning Circulation, February 26, 2008; 117(8): 1037 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Goldfarb, S. Arnold, and J. Han Recent Myocardial Infarction: Assessment with Unenhanced T1-weighted MR Imaging Radiology, October 1, 2007; 245(1): 245 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G Assomull, D. J Pennell, and S. K Prasad Cardiovascular magnetic resonance in the evaluation of heart failure Heart, August 1, 2007; 93(8): 985 - 992. [Full Text] [PDF] |
||||
![]() |
J. T. Ortiz-Perez, S. N. Meyers, D. C. Lee, P. Kansal, F. J. Klocke, T. A. Holly, C. J. Davidson, R. O. Bonow, and E. Wu Angiographic estimates of myocardium at risk during acute myocardial infarction: validation study using cardiac magnetic resonance imaging Eur. Heart J., July 2, 2007; 28(14): 1750 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Gerber Risk area, infarct size, and the exposure of the wavefront phenomenon of myocardial necrosis in humans Eur. Heart J., July 2, 2007; 28(14): 1670 - 1672. [Full Text] [PDF] |
||||
![]() |
B. Ibanez, S. Prat-Gonzalez, W. S. Speidl, G. Vilahur, A. Pinero, G. Cimmino, M. J. Garcia, V. Fuster, J. Sanz, and J. J. Badimon Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage: Analysis of Ischemic Myocardium at Risk Using Cardiac Magnetic Resonance Circulation, June 12, 2007; 115(23): 2909 - 2916. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Assomull, J. C. Lyne, N. Keenan, A. Gulati, N. H. Bunce, S. W. Davies, D. J. Pennell, and S. K. Prasad The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries Eur. Heart J., May 3, 2007; (2007) ehm113v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pennell Myocardial Salvage: Retrospection, Resolution, and Radio Waves Circulation, April 18, 2006; 113(15): 1821 - 1823. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |